2019 AABB Annual Meeting Session

"What's New with Reimbursement and Coding for Blood Products, Transfusion Medicine and Cellular Therapies?" will provide attendees with an update on billing requirements and reimbursement policies that impact blood products, transfusion medicine and cellular therapies. In addition, speakers will discuss AABB's activities related to coding and reimbursement. Session attendees will have the opportunity to have their coding and billing questions answered by the experts.

Learning Objectives:

Describe updates to relevant Medicare policies impacting reimbursement for blood and transfusion medicine.
Describe updates to payment policies for cellular therapies.
Describe recent advocacy initiatives aimed at ensuring appropriate Medicare reimbursement for blood, transfusion medicine and cellular therapies.

Roxanne M. Tata MT(ASCP) SBB:CQA

Vice President, Quality System and Regulatory Services, Vitalant

Appearances